Related Experiment Video
Updated: Apr 13, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
[Lipid - lowering effect of mate tea intake in dyslipidemic subjects]
Diego Messina1, Catalina Soto2, Ailín Méndez3
1Laboratorio de Enfermedades Metabólicas y Cáncer. Facultad de Ciencias de la Nutrición. Universidad Juan Agustín Maza. Mendoza, Argentina.. diego_messi@hotmail.com.
Introduction:
Mate is the national infusion of Argentina and its properties on human health have not been fully elucidated.
Objective:
To evaluate changes in lipid profile in dyslipidemic patients supplemented with yerba mate.
Methods:
121 dyslipidemic subjects (total cholesterol (TC), LDL cholesterol (LDLC) cholesterol and / or triglycerides (TG) elevated) without lipid-lowering therapy, both sexes (74 women and 47 men) between 40 and 60 years old were studied. After six weeks of mate abstinence, lipid profile and atherogenic index (AI), body composition by anthropometry and recent intake of energy, nutrients and food groups by food frequency questionnaire were analyzed. Daily consumption of mate prepared with 50 g or 100 g of yerba mate was indicated, plus the instruction not to alter eating habits, smoking, medication or exercise. All determinations were repeated after six and twelve weeks. Statistical analysis was performed using Student's T test for paired samples or Wilcoxon test according to normality of the variables (p <0.05).
Results:
At the end of twelve weeks, TC fell 9.49% (21.66 mg/dL), LDLC fell 11.95% (17.96 mg/dL) HDLC fell 3.34% (1.65 mg/dL) and AI dropped 6.58% (0.31 points), p <0.001 for all cases. TG decreased 7.02% (10.74 mg/dl; p = 0.029) only in 50 g yerba mate consumers. Anthropometric and nutritional variables did not change significantly.
Conclusions:
Daily consumption of mate produces a time-dependent decrease in TC and its fractions in dyslipidemic subjects.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management